According to a new market analysis report released today by Future Market Insights, the global familial hypercholesterolemia (FH) treatment market is valued at USD 2,321.9 million in 2026 and is expected to reach USD 4,525.0 million by 2036, reflecting a compound annual growth rate (CAGR) of 6.9% during the forecast period. Familial hypercholesterolemia...